Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness Study (ORBEX)

The UW Pediatric Asthma Research Program is looking for infants (5 to 16 month olds) with a history of eczema or a parent with physician-diagnosed asthma to participate in a research study.

This study will see if a daily capsule of the investigational medication Broncho-Vaxom^® (a mixture of bacteria products) helps prevent at-risk infants from developing wheezing illness or asthma.